EP3668856
NÝ TETRASÓL EFNASAMBÖND OG NOTKUN ÞEIRRA VIÐ MEÐFERÐ Á BERKLUM
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
16.8.2018EP published:
23.6.2021EP application number:
18755815.0
EP translation filed:
17.9.2021Grant published:
15.11.2021EPO information:
European Patent Register
Max expiry date:
15.8.2038Expiry date:
15.8.2026Next due date:
31.8.2026
Title:
NOVEL TETRAZOLE COMPOUNDS AND THEIR USE IN THE TREATMENT OF TUBERCULOSIS
Timeline
Today
16.8.2018EP application
23.6.2021EP Publication
17.9.2021Translation submitted
15.11.2021Registration published
15.8.2026Expires
Owner
Name:
GlaxoSmithKline Intellectual Property Development LimitedAddress:
GSK Medicines Research Centre, Gunnels Wood Road, Stevenage SG1 2NY, GB
Inventor
Name:
ALEMPARTE-GALLARDO, CarlosAddress:
28760 Madrid, ES
Name:
ENCINAS, LourdesAddress:
28760 Madrid, ES
Name:
ESQUIVIAS PROVENCIO, JorgeAddress:
28760 Madrid, ES
Agent
Name:
Tego ehf.Address:
Pósthólf 8129, 128, Reykjavík,
Priority
Number:
17382574Date:
17.8.2017Country:
EP
Classification
Categories:
C07D 401/06, C07D 403/06, C07D 405/06, C07D 249/06, C07D 257/04, A61P 31/06, A61K 31/4192, A61K 31/4196, A61K 31/506, A61K 31/4439, A61K 31/497, A61K 31/501
Annual fees
Number
Paid
Expires
Payer
Number: 4
Paid: 26.7.2021
Expires: 15.8.2022
Payer: Patice ehf.
Number: 5
Paid: 20.7.2022
Expires: 15.8.2023
Payer: Patice ehf.
Number: 6
Paid: 20.7.2023
Expires: 15.8.2024
Payer: Árnason Faktor ehf.
Number: 7
Paid: 23.7.2024
Expires: 15.8.2025
Payer: Árnason Faktor ehf.
Number: 8
Paid: 12.8.2025
Expires: 15.8.2026
Payer: Árnason Faktor ehf.